Table 1

 Characteristics of subjects

Non-smokers(n = 10)Healthy smokers(n = 12)Stable COPD(n = 7)Severe exacerbations of COPD(n = 7)Very severe exacerbations of COPD(n = 7)
Values are shown as mean (SE).
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; Pao2, Paco2, arterial oxygen and carbon dioxide tensions; NA, not applicable; ND, not done.
*p<0.05, **p<0.01, ***p<0.001 compared with non-smokers.
†p<0.05, ††p<0.01, †††p<0.001 compared with smokers.
Age (years)53.5 (2.5)50.3 (2.1)70.3 (5.4)**†††57.8 (3.5)69.9 (1.6)**†††
M/F4/66/64/37/07/0
FEV1 when stable (l)3.4 (0.4)3.1 (0.2)2.47 (0.4)**0.89 (0.2)***†††0.9 (0.2)***†††
FEV1 % predicted when stable116.3 (7.7)98.5 (3.9) *63.7 (7.5)***†28.6 (0.14)***††31.4 (6.9)***†††
FEV1/FVC ratio (%)75.3 (2.6)74.4 (1.8)58.8 (2.9)42.8 (6.5)**†46.0 (7.2)**†
Smoking (pack years)NA41 (6)38 (12)52 (5)58 (6)†
Pao2/Paco2 (kPa)NDNDND8.9 (0.4)/6.0 (0.3)6.7 (1.4)/9.1 (1.1)
Oral corticosteroids (Y/N)–/––/––/7–/83/5
Inhaled corticosteroids (Y/N)–/72/57/1